Tinzaparin vs Warfarin for Acute Venous Thromboembolism--Reply

JAMA. 2016 Jan 12;315(2):200-1. doi: 10.1001/jama.2015.15070.

Authors

Alok A Khorana¹, Agnes Y Y Lee²; CATCH Steering Committee

Affiliations

¹ Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
² Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, Canada.

PMID: 26757472
DOI: 10.1001/jama.2015.15070

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants / therapeutic use*
Female
Heparin, Low-Molecular-Weight / therapeutic use*
Humans
Male
Venous Thromboembolism / drug therapy*
Warfarin / therapeutic use*

Substances

Anticoagulants
Heparin, Low-Molecular-Weight
Warfarin